InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer (NCT05463796)
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk For Cancer
🩺 Plain-English Summary (8th-Grade Level)
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The objective of this study is to identify exposures as well as clinical, molecular, and pathological changes that can be used to predict early development of cancer, malignant transformation, and risks of progression to symptomatic cancer that can ultimately be fatal. * The ultimate goal is to identify novel markers of early detection and risk stratification to drive potential therapeutic approaches to intercept progression to cancer.
Who can join: Review the eligibility criteria below.
Location: Dana Farber Cancer Institute — Boston, Massachusetts
🧪 Interventions in This Study
- Samples (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Dana Farber Cancer Institute — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (857) 215-1892
Email: inadvancestudy@dfci.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer Risk
- Cancer PRevention Through Enhanced EnvironMenT — Birmingham, Alabama
- Mirai-MRI: Validation of AI Models for Breast Cancer Risk — San Diego, California
- CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management — Totowa, New Jersey
- Clinical Biospecimen Collection — Shirley, New York
- A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer — Aurora, Colorado
Explore by condition: All Cancer Risk clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.